Anthera Pharmaceuticals, Inc Company Profile

Aggregated data from the web about Anthera Pharmaceuticals, Inc

Company Name	Anthera Pharmaceuticals, Inc
Website	Anthera.com
Snippet	Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera’s leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy[1][2] is currently in Phase 2 clinical trial.
Type	Public
Founded	2004
Website	Anthera.com
Industry	Pharmaceuticals
Traded as	NASDAQ: ANTH
Key people	Craig Thompson(President and CEO)
Headquarters	Hayward, California, U.S.

Anthera Pharmaceuticals, Inc is part of the United States company list

Anthera Pharmaceuticals, Inc is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.